Vivian Health raises $60M led by Thoma Bravo (with IAC, Collaborative Fund)

What's the deal? On 26 April 2022, IAC's Vivian Health announced a $60 million primary and secondary equity investment led by Thoma Bravo, with participation from IAC and Collaborative Fund. Capital was earmarked for growth, marketplace scale, and future M&A.

Context: IAC had acquired Nursefly (later Vivian Health) in August 2019. IAC remained an investor alongside Thoma Bravo after the 2022 round.

Source: PR Newswire / Thoma Bravo.